Your browser doesn't support javascript.
loading
Treatment for T1DM patients by a neuro-fuzzy inverse optimal controller including multi-step prediction.
Rios, Y Yuliana; García-Rodríguez, J A; Sanchez, Edgar N; Alanis, Alma Y; Ruiz-Velázquez, E; Pardo Garcia, Aldo.
Afiliação
  • Rios YY; GAICO, Grupo de Automatización y Control, Universidad Tecnológica de Bolívar, Cartagena de Indias, Bolívar, Colombia. Electronic address: yrios@utb.edu.co.
  • García-Rodríguez JA; CUCEI, Electronics and Computing Division, Universidad de Guadalajara, Guadalajara, Jalisco, Mexico.
  • Sanchez EN; CINVESTAV, Electrical Engineering Department, Zapopan, Jalisco, Mexico.
  • Alanis AY; CUCEI, Electronics and Computing Division, Universidad de Guadalajara, Guadalajara, Jalisco, Mexico.
  • Ruiz-Velázquez E; CUCEI, Electronics and Computing Division, Universidad de Guadalajara, Guadalajara, Jalisco, Mexico.
  • Pardo Garcia A; A&C, Grupo de Automatización y Control, Universidad de Pamplona, Pamplona, Norte de Santander, Colombia.
ISA Trans ; 126: 203-212, 2022 Jul.
Article em En | MEDLINE | ID: mdl-34446285
Diabetes Mellitus is a serious metabolic condition for global health associations. Recently, the number of adults, adolescents and children who have developed Type 1 Diabetes Mellitus (T1DM) has increased as well as the mortality statistics related to this disease. For this reason, the scientific community has directed research in developing technologies to reduce T1DM complications. This contribution is related to a feedback control strategy for blood glucose management in population samples of ten virtual adult subjects, adolescents and children. This scheme focuses on the development of an inverse optimal control (IOC) proposal which is integrated by neural identification, a multi-step prediction (MSP) strategy, and Takagi-Sugeno (T-S) fuzzy inference to shape the convenient insulin infusion in the treatment of T1DM patients. The MSP makes it possible to estimate the glucose dynamics 15 min in advance; therefore, this estimation allows the Neuro-Fuzzy-IOC (NF-IOC) controller to react in advance to prevent hypoglycemic and hyperglycemic events. The T-S fuzzy membership functions are defined in such a way that the respective inferences change basal infusion rates for each patient's condition. The results achieved for scenarios simulated in Uva/Padova virtual software illustrate that this proposal is suitable to maintain blood glucose levels within normoglycemic values (70-115 mg/dL); furthermore, this level remains less than 250 mg/dL during the postprandial event. A comparison between a simple neural IOC (NIOC) and the proposed NF-IOC is carried out using the analysis for control variability named CVGA chart included in the Uva/Padova software. This analysis highlights the improvement of the NF-IOC treatment, proposed in this article, on the NIOC approach because each subject is located inside safe zones for the entire duration of the simulation.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 1 Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 1 Idioma: En Ano de publicação: 2022 Tipo de documento: Article